Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Chiyomi Egawa"'
Autor:
Kazuhiro Araki, Yoshinori Ito, Ippei Fukada, Kokoro Kobayashi, Yoshimasa Miyagawa, Michiko Imamura, Ayako Kira, Yuichi Takatsuka, Chiyomi Egawa, Hirofumi Suwa, Shinji Ohno, Yasuo Miyoshi
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstracts Background Although peripheral blood-based parameters (PBBPs) are reported as prognostic indicators in patients with breast cancers, their utility has not been studied in human epidermal growth factor receptor 2 (HER2)-positive advanced bre
Externí odkaz:
https://doaj.org/article/29f5a70f15404664a88f5d345caa82d3
Autor:
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Treatment with an aromatase inhibitor for 5 years is the standard treatment for postmenopausal hormone receptor–positive breast cancer. We investigated the effects of extending this treatment to 10 years on disease-free survival (DFS). PATI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6f2d4102ddb2138952c3a6670a822d8
https://doi.org/10.1200/jco.22.00577
https://doi.org/10.1200/jco.22.00577
Autor:
Junji Tsurutani, Takashi Yamanaka, Hirofumi Mukai, Chiyomi Egawa, Hiroki Ikezawa, Yukinori Sakata, Kenzo Muramoto, Masato Takahashi, Yasuo Miyoshi, Toshiyuki Matsuoka, Kenichi Inoue
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background It was reported that eribulin regulates the tumor microenvironment, including the immune system, by inducing vascular remodeling. Lymphocyte counts are a critical index of immune response in patients. The non-Asian, global EMBRACE study ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2987079552c5864311f5bbb5ae063f2e
https://doi.org/10.1007/s12282-021-01232-1
https://doi.org/10.1007/s12282-021-01232-1
Autor:
Takehiro, Yanagawa, Kaori, Kikumori, Kazuteru, Oshima, Chiyomi, Egawa, Yuichi, Takatsuka, Shinsuke, Katsuyama, Go, Shinke, Kenji, Kawai, Masayuki, Hiraki, Yoshiteru, Katsura, Yoshiaki, Ohmura, Toru, Masuzawa, Taishi, Hata, Yutaka, Takeda, Kohei, Murata
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(3)
We report a case of sphenoid bone metastasis from breast cancer detected with diplopia, as first site of recurrence. Forty- year-old woman with left breast cancer underwent breast-conserving surgery and sentinel lymph node biopsy. The diagnosis was p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d096a40f3a9081cd1807df2edef72e5f
https://pubmed.ncbi.nlm.nih.gov/35299194
https://pubmed.ncbi.nlm.nih.gov/35299194
Autor:
Shintaro Takao, Seishi Kono, Masaru Miyashita, Muneharu Konishi, Ikuo Kokufu, Hirofumi Suwa, Koushiro Kitatsuji, Yutaka Konishi, Isao Sakita, Masayuki Nishino, K Yamagami, Hidefumi Nishikawa, Masahiro Kishimoto, Keisuke Miyauchi, Takashi Matsumoto, Toshitaka Okuno, Akihiro Miya, Koushi Oh, Masashi Baba, Kazuyuki Wakita, Toshiharu Hidaka, Takashi Hashimoto, Yoko Sakoda, Shigetoshi Ichii, Yasuo Miyoshi, Junya Minohata, Yuichiro Kikawa, Chiyomi Egawa
Publikováno v:
Cancer Research. 80:P5-12
Background Five-year adjuvant treatment with aromatase inhibitors is a standard treatment for postmenopausal women with estrogen receptor-positive breast cancer. However, aromatase inhibitor-related adverse events, including joint and vasomotor sympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f0dda4eab31d3ae4987c4c8337ee5f
https://doi.org/10.1158/1538-7445.sabcs19-p5-12-07
https://doi.org/10.1158/1538-7445.sabcs19-p5-12-07
Autor:
Yasuo Miyoshi, Yoshimasa Miyagawa, Chiyomi Egawa, Atsushi Sata, Takehiro Yanagawa, Takashi Morimoto, Hiromi Ozawa, Ayako Bun, Kaori Takamoto, Yukie Fujimoto, Arisa Nishimukai, Tomoko Higuchi, Reiko Fukui, Jyunichi Inatome, Ayako Yanai, Michiko Imamura
Publikováno v:
Cancer Research. 80:P3-08
Background Vascular endothelial growth factor (VEGF) is a key player in angiogenesis, and bevacizumab, a humanized monoclonal antibody against VEGF-A, is already utilized in daily clinical practice coupled with chemotherapy for locally advanced and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ce040f00b421a6752e2667f88efbe96
https://doi.org/10.1158/1538-7445.sabcs19-p3-08-49
https://doi.org/10.1158/1538-7445.sabcs19-p3-08-49
Autor:
Ai Yamaguchi, Michiko Imamura, Yuki Okada, Tomoe Taji, Arisa Nishimukai, Tomoko Higuchi, Ayako Yanai, Takashi Morimoto, Takehiro Yanagawa, Ayako Bun, Hirofumi Suwa, Yuichiro Kikawa, Yasuo Miyoshi, Yoshimasa Miyagawa, Atsushi Sata, Hiromi Ozawa, Chiyomi Egawa, Kaori Takamoto, Yukie Fujimoto, Reiko Fukui, Junichi Inatome
Publikováno v:
Oncotarget
The effect of bevacizumab plus paclitaxel therapy on progression-free survival (PFS) is prominent; however, no overall survival (OS) benefit has been demonstrated. Our aim was to study the predictive efficacy of peripheral immune-related parameters,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca24d06cc15485350000b8b955ccc710
https://doi.org/10.18632/oncotarget.27423
https://doi.org/10.18632/oncotarget.27423
Autor:
Hiroki Ikezawa, Chiyomi Egawa, Junji Tsurutani, Toshiyuki Matsuoka, Kenichi Inoue, Hirofumi Mukai, Yukinori Sakata, Masato Takahashi, Takashi Yamanaka
Publikováno v:
Investigational New Drugs
SummaryBackground Data on eribulin as the first- or second-line treatment in a clinical setting, especially the overall survival (OS) of patients, are scarce. Therefore, we assessed the effectiveness and safety of eribulin as the first-, second-, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6b2b56d581e621be3a22733f06c428
http://europepmc.org/articles/PMC7497681
http://europepmc.org/articles/PMC7497681
Autor:
Kazuteru, Oshima, Kaori, Kikumori, Takehiro, Yanagawa, Chiyomi, Egawa, Yuichi, Takatsuka, Go, Shinke, Shinsuke, Katsuyama, Kenji, Kawai, Masayuki, Hiraki, Yoshiteru, Katsura, Yoshiaki, Ohmura, Toru, Masuzawa, Taishi, Hata, Yutaka, Takeda, Kohei, Murata
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(13)
The patient is an 85-year-old female who had previously undergone a mastectomy for right breast cancer at the age of 42 years. In September 2020, she visited our hospital with a chief complaint of a chest wall tumor. Physical examination revealed a 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81872de27bc300dae730d5d6101c3524
https://pubmed.ncbi.nlm.nih.gov/35046350
https://pubmed.ncbi.nlm.nih.gov/35046350
Autor:
Kaori, Kikumori, Kazuteru, Oshima, Takehiro, Yanagawa, Chiyomi, Egawa, Yuichi, Takatsuka, Go, Shinke, Shinsuke, Katsuyama, Kenji, Kawai, Masayuki, Hiraki, Yoshiteru, Katsura, Yoshiaki, Ohmura, Toru, Masuzawa, Taishi, Hata, Yutaka, Takeda, Kohei, Murata
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(13)
The patient was a 56-year-old woman. who was aware of a tumor in her left axilla and consulted a nearby doctor. She was referred to our hospital for a detailed examination. No abnormalities were found in the breast by visual inspection, mammography,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c80fa374a40f1cc90f73aa52ed04b7cd
https://pubmed.ncbi.nlm.nih.gov/35045425
https://pubmed.ncbi.nlm.nih.gov/35045425